Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Urologist's Personal View of Prostate Cancer.

Literature DB >> 27635283

A Urologist's Personal View of Prostate Cancer.

Abstract

A urologist's personal experience with multiple surgical, hormonal, and radio/immunotherapeutic options for the treatment of advanced prostate cancer and thoughts on the role of old and new therapies.

Entities: Disease

Keywords: Cancer; prostate; treatment

Year: 2016 PMID： 27635283 PMCID： PMC5012435 DOI： 10.5152/tud.2016.50318

Source DB: PubMed Journal: Turk J Urol ISSN： 2149-3235

34 in total

1. The two faces of janus: sex steroids as mediators of both cell proliferation and cell death.

Authors: A M Soto; C Sonnenschein
Journal: J Natl Cancer Inst Date: 2001-11-21 Impact factor: 13.506

2. Gonadal steroids and body composition, strength, and sexual function in men.

Authors: Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder
Journal: N Engl J Med Date: 2013-09-12 Impact factor: 91.245

3. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.

Authors: D P Byar; D K Corle
Journal: NCI Monogr Date: 1988

4. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

Authors: Celestia S Higano; Paul F Schellhammer; Eric J Small; Patrick A Burch; John Nemunaitis; Lianng Yuh; Nicole Provost; Mark W Frohlich
Journal: Cancer Date: 2009-08-15 Impact factor: 6.860

5. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

Authors: Frédéric E Lecouvet; Daphné Geukens; Annabelle Stainier; François Jamar; Jacques Jamart; Bertrand Janne d'Othée; Patrick Therasse; Bruno Vande Berg; Bertrand Tombal
Journal: J Clin Oncol Date: 2007-08-01 Impact factor: 44.544

6. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors: Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal: J Clin Oncol Date: 2009-05-11 Impact factor: 44.544

7. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors: Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal: J Clin Oncol Date: 2007-05-20 Impact factor: 44.544

8. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

Authors: Gregory P Swanson; Michael A Hussey; Catherine M Tangen; Joseph Chin; Edward Messing; Edith Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford
Journal: J Clin Oncol Date: 2007-06-01 Impact factor: 44.544